The role of neuropeptides in sleep modulation

Drug News and Perspectives

Volumn 17, Issue 8, 2004, Pages 518-522

  Prospéro García, Oscar ^a   Méndez Díaz, Mónica ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CHOLECYSTOKININ OCTAPEPTIDE; CORTISTATIN; GHRELIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; INSULIN; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; LEPTIN; NERVE GROWTH FACTOR; NEUROPEPTIDE; NEUROPEPTIDE Y; NEUROTROPHIN 3; NEUROTROPHIN 4; OREXIN; PROLACTIN; SOMATOSTATIN; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ALERTNESS; CELL STRUCTURE; ENERGY METABOLISM; FEEDING; FOOD INTAKE; GENE EXPRESSION; GENOME; IMMUNE SYSTEM; NERVE CELL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REM SLEEP; REVIEW; SIGNAL TRANSDUCTION; SLEEP; SLEEP WAKING CYCLE; WAKEFULNESS;

ANIMALS; HUMANS; MEXICO; NEUROPEPTIDES; SLEEP STAGES;

EID: 10444248702     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2004.17.8.863695     Document Type: Review

References (47)

1. Obal, F. Jr., Sary, G., Alfoldi, P. and Rubicsek Obal, F. Vasoactive intestinal polypeptide promotes sleep without effects on brain temperature in rats at night. Neurosci Lett 1986, 64: 236-40.
2. Prospéro-García, O., Morales, M., Arankowsky-Sandoval, G. and Drucker-Colín, R. Vasoactive intestinal poypeptide (VIP) and cerebrospinal fluid of sleep-deprived cats restores REM sleep in insomniac recipients. Brain Res 1986, 385: 169-73.
3. Prospéro-García, O., Jiménez-Anguiano, A. and Drucker-Colín, R. The combination of VIP and atropine induces REM sleep in cats rendered insomniac. Neuropsycopharmacology 1993, 8: 387-90.
4. Jimenez-Anguiano, A., Baez-Saldaña, A. and Drucker-Colín, R. Cerebral fluid (CSF) extracted immediately after REM sleep deprivation prevents REM rebound and contains Vasoactive intestinal polypeptide (VIP). Brain Res 1993, 631: 345-8.
5. Jimenez-Anguiano, A., García-García, F., Mendoza-Ramirez, J.L., Duran-Vazquez, A. and Drucker-Colín, R. Brain distribution of vasoactive intestinal polypeptide receptors following REM sleep deprivation. Brain Res 1996, 728: 37-46.
6. Bredow, S., Kacsoh, B., Obal, F. Jr., Fang, J. and Krueger, J.M. Increase of prolactin mRNA in the rat hypothalamus after intracerebroventricular injection of VIP or PACAP. Brain Res 1994, 660: 301-8.
7. Obal, F. Jr., Payne, L., Kacsoh, B. et al. Involvement of prolactin in the REM sleep-promoting activity of systemic vasoactive intestinal polypeptide (VIP). Brain Res 1994, 645: 143-9.
8. Bourgin, P., Anhnaou, A., Laporte, A.M., Hamon, M. and Adrien, J. Rapid eye movement sleep induction by vasoactive intestinal peptide infused into oral pontine tegmentum of the rat may involve muscarinic receptors. Neuroscience 1999, 89: 291-302.
9. Simon-Arceo, K., Ramírez-Salado, I. and Calvo, J.M. Long-lasting enhancement of rapid eye movement sleep and pontogeniculooccipital waves by vasoactive intestinal peptide microinjection into the amygdala temporal lobe. Sleep 2003, 26: 259-64.
10. Prospéro-García, O., Ott, T. and Drucker-Colín, R. Cerebroventricular infusion of cholecystokinin (CCK-8) restores EM sleep in parachlorophenylalanine (PCPA)-pretreated cats. Neurosci Lett 1987, 78: 205-10.
11. Kapas, L., Obal, F. Jr., Alfoldi, P., Rubicsek, G., Penke, B. and Obal, F. Effects of nocturnal intraperitoneal administration of cholecystokinin in rats: Simultaneous increase in sleep, increase in EEG slow-wave activity, reduction of motor activity, suppression of eating, and decrease in brain temperature. Brain Res 1988, 438: 155-64.
12. Kapas, L., Obal F. Jr., Opp, M.R., Johannsen, L. and Krueger, J.M. Intraperitoneal injection of cholecystokinin elicits sleep in rabbits. Physiol Behav 1991, 50: 1241-4.
13. Crawley, J.N. and Corwin, R.L. Biological actions of cholecystokinin. Peptides 1994, 15: 731-55.
14. Crespi, F. Cholecystokinin-B (CCK-B) receptor antagonists improve "aged" sleep: A new class of sleep modulators? Methods Find Exp Clin Pharmacol 1999, 21: 31-8.
15. Chang, H.Y. and Kapas, L. Selective activation of CCK-B receptors does not induce sleep and does not affect EEG slow-wave activity and brain temperature in rats. Physiol Behav 1997, 62: 175-9.
16. Sei, M., Sei, H. and Shima, K. Spontaneous activity, sleep, and body temperature in rats lacking the CCK-A receptor. Physiol Behav 1999, 68: 25-9.
17. Shemyakin, A. and Kapas, L. L-364,718, a cholecystokinin-A receptor antagonist, suppresses feeding-induced sleep in rats. Am J Physiol Regul Integr Comp Physiol 2001, 280: R1420-6.
18. Chastrette, N., Cespuglio, R. and Jouvet, M. Proopiomelanocortin (POMC)-derived peptides and sleep in the rat. Part 1: Hypnogenic properties of ACTH derivates. Neuropeptides 1990, 15: 61-74.
19. Leger, L., Lema, F., Chastrette, N. et al. Monoclonal antibody directed against CLIP (ACTH18-39). Anatomical distribution of immunoreactivity in the rat brain and hypophysis with quantification of the hypothalamic cell group. J Chem Neuroanat 1990, 3: 297-308.
20. Zaphiropoulos, A., Charnay, Y., Vallet, P., Constantinidis, J. and Bouras C. Immunohistochemical distribution of corticotropin-like intermediate lobe peptide (CLIP) immunoreactivity in the human brain. Brain Res Bull 1991, 26: 99-111.
21. Wetzel, W., Balschun, D., Janke, S., Vogel, D. and Wagner, T. Effects of CLIP (corticotropin-like intermediate lobe peptide) and CLIP fragments on paradoxical sleep in rats. Peptides 1994, 637: 211-21.
22. Wetzel, W., Wagner, T., Vogel, D., Demuth, H.U. and Balschun, D. Effects of the CLIP fragmented ACTH 20-24 on the duration of REM sleep episodes. Neuropeptides 1997, 31: 41-5.
23. Leger, L., Bonnet, C., Cespuglio, R. and Jouvet, M. Immunocytochemical study of the CLIP/ACTH-immunoreactive nerve fibres in the dorsal raphe nucleus of the rat. Neurosci Lett 1994, 174: 137-40.
24. el Kafi, B., Leger, L., Seguin, S., Jouvet, M. and Cespuglio, R. Sleep permissive components within the dorsal raphe nucleus in the rat. Brain Res 1995, 751: 54-63.
25. Steiger, A., Antoijevic, I.A., Bohlhalter, S., Frieboes, R.M., Friess, E. and Murck, H. Effects of hormones on sleep. Horm Res 1998, 49: 125-30.
26. Van Cauter, E., Plat, L. and Copinschi, G. Interrelations between sleep and somatotropic axis. Sleep 1998, 21: 553-66.
27. Sakurai, T. Roles of orexins in regulation of feeding and wakefulness. Neuroreport 2002, 13: 987-95.
28. Preti, A. Orexins (hypocretins): Their role in appetite and arousal. Curr Opin Investig Drugs 2002, 3: 1199-206.
29. Chemelli, R.M., Willie, J.T., Sinton, C.M. et al. Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation. Cell 1999, 98: 437-51.
30. Gerashchenko, D., Blanco-Centurion, C., Greco, M.A. and Shiromani, P.J. Effects of lateral hypothalamic lesion with the neurotoxin hypocretin-2-saporin on sleep in Long-Evans rats. Neuroscience 2003, 116: 223-35.
31. Brown, R.E. Involvement of hypocretins/orexins in sleep disorders and narcolepsy. Drug News Perspect 2003, 16: 75-9.
32. Kohlmeier, K.A., Inoue, T. and Leonard, C.S. Hypocretins/orexin peptide signalling in the ascending arousal system: Elevation of intracellular calcium in the mouse dorsal raphe and laterodorsal tegmentum. J Neurophysiol 2004, 92: 221-35.
33. Smith, M.I., Piper, D.C., Duxon, M.S. and Upton, N. Evidence implicating a role for orexin receptor modulation of paradoxical sleep in the rat. Neurosci Lett 2003, 341: 256-8.
34. Pedrazzoli, M., D'Almeida, V., Martins, P.J. et al. Increased hypocretin-1 levels in cerebrospinal fluid after REM sleep deprivation. Brain Res 2004, 995: 1-6.
35. de Lecea, L., Criado, J.R., Prospéro-García, O. et al. A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature 1996, 381: 242-5.
36. Connor, M., Ingram, S.L. and MacDonald, J.C. Cortistatin increase of a potassium conductance in rat locus coeruleus in vitro. Br J Pharm 1997, 122: 1567-72.
37. de Lecea, L., Ruiz-Lozano, P., Danielson, P.E. et al. Cloning, mRNA expression, and chromosomal mapping of mouse and human preprocortistatin. Genomics 1997, 42: 499-506.
38. Fukusumi, S., Kitada, C., Takekawa, S. et al. Identification and characterization of a novel human cortistatin-like peptide. Biochem Biophys Res Comm 1997, 232: 157-63.
39. Flood, J.F., Uezu, K. and Morley, J.E. The cortical neuropeptide, cortistatin-14, impairs post-training memory processing. Brain Res 1997, 775: 250-2.
40. Sánchez-Alavez, M., Gómez-Chavarín, M., Navarro, L. et al. Cortistatin modulates memory processes in rats. Brain Res 2000, 858: 78-83.
41. Méndez-Díaz, M., Guevara-Martínez, M., Alquicira, C.R., Guzmán-Vásquez, K. and Prospéro-García, O. Cortistatin, a modulatory peptide of sleep and memory, induces analgesia in rats. Neurosci Lett 2004, 354: 242-4.
42. Quiroz-Torres, A.M., Méndez-Diaz, M., Rueda, P., Gonzalez-Rivera, R., Haro, R. and Prospero-García, O. Cortistatin, a sleep inducing peptide regulates food intake. Soc Neurosci 2002, 89.6.
43. Robas, N., Mead, E. and Fidock, M. MrgX2 is a potency cortistatin receptor expressed in dorsal root ganglion. J Biol Chem 2003, 278: 44400-4.
44. Krueger, J.M., Obal, F.J., Fang, J., Kubota, T. and Taishi, P. The role of cytokines in physiological sleep regulation. Ann NY Acad Sci 2001, 933: 211-21.
45. Krueger, J.M. and Majde, J.A. Humoral links between sleep and the immune system: Research issues. Ann NY Acad Sci 2003, 992: 9-20.
46. Kushikata, T., Kubota, T., Fang, J. and Krueger, J.M. Neurotrophins 3 and 4 enhance non-rapid eye movement sleep in rabbits. Neurosci Lett 2003, 346: 161-4.
47. Sei, M., Sayito, D., Yamamoto, K. and Morita, Y. Differential effect of short-term REM sleep deprivation on NGF and BDNF protein levels in the rat brain. Brain Res 2000, 877: 387-90.